Mon panier

LIV-1

LIV-1 Informations sur la molécule

Nom anglaisZinc transporter ZIP6Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2Alias de la cibleLIV-1,LIV1,LIV-1 Protein, Estrogen Regulated,Solute Carrier Family 39 (Metal Ion Transporter), Member 6,Zrt- and Irt-like protein 6,SLC39A6,Estrogen-regulated protein LIV-1,ZIP-6,Zinc transporter ZIP6,Solute Carrier Family 39 (Zinc Transporter), Member 6,Solute carrier family 39 member 6
Phase de R&D la plus avancéePhase 2 Clinical
Nom anglaisZinc transporter ZIP6
Alias de la cibleLIV-1,LIV1,LIV-1 Protein, Estrogen Regulated,Solute Carrier Family 39 (Metal Ion Transporter), Member 6,Zrt- and Irt-like protein 6,SLC39A6,Estrogen-regulated protein LIV-1,ZIP-6,Zinc transporter ZIP6,Solute Carrier Family 39 (Zinc Transporter), Member 6,Solute carrier family 39 member 6
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2
Phase de R&D la plus avancéePhase 2 Clinical

LIV-1 Liste de produits

  • Attribut

    Protein (14)

  • Bibliothèque de produits

    En ligne (14)

  • Espèces

    Human (7)Cynomolgus (3)Rat (1)Mouse (2)Rhesus macaque (1)

  • Étiquette

    Fc Tag (4)His Tag (6)His Tag & Avi Tag (2)Fc Tag & Avi Tag (1)- (1)

  • Marqueur

    Unconjugated (11)Biotin-labeled (3)

LIV-1Contexte de la molécule

LIV-1 is also known as SLC39A6, ZIP-6 and Zinc transporter ZIP6. May act as a zinc-influx transporter. Highly expressed in the breast, prostate, placenta, kidney, pituitary and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma. Up-regulated by estrogen in breast cancer cells lines.

LIV-1Alias de la molécule

SLC39A6,LIV-1,ZIP6,Zinc transporter ZIP6,ZIP-6

Plateforme de commerce de projets d'anticorps

Nom du projetPhase du projetType de moléculeSource de moléculeDomain thérapeutiqueIndication
LIV-1 mAb - 01PCCMonoclonalHumanized MouseSolid TumorColorectal cancer,Breast cancer

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
Ladiratuzumab vedotinSGN-LIV1A; MK-6440; MK6440Phase 2 ClinicalMerck Sharp & Dohme Corp, Seagen IncBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Gastroesophageal Junction Neoplasms; Melanoma; Metastatic breast cancer; Prostatic Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms
Details
LaventatugBRY-812Phase 2 ClinicalZhejiang BioRay Biopharmaceuticals Co LtdNeoplasms; Solid tumours
Details

Avis sur les produits

  • J***g2022-04-13
    2Mettre un like
    When I was searching for this protein, there were not many options until I found ACRO. Very happy about various species as well as tag choices. ELISA results are reproducible and consistent. The delivery was fast whereas others may take longer. The product information is clear and comprehensive, which is very important for the research.
  • Informations sur la molécule
  • Liste de produits
  • Avis sur les produits
  • Informations sur les médicaments cliniques